Quest Diagnostics SVP adds options for 1,386 shares
Alpha Vantage · Benzinga · · AI-summarised by FinFlash
Subu Ramachandran, SVP at Quest Diagnostics, acquired stock options for 1,386 shares worth $6,063 on November 6, per an SEC filing. The diagnostic testing provider posted revenue growth of 9.98% as of September 30, 2026, with a 33.65% gross margin and a P/E of 25.37.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.